Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 12 matching records.
12 results — page 1 of 1
- Level DAnimal StudyPubMed
Decellularized Placental Sponge Seeded with Human Mesenchymal Stem Cells Improves Deep Skin Wound Healing in the Animal Model.
Animal Study on Chronic Wound, published in ACS Appl Bio Mater (2024) — summary generated from the PubMed abstract.
- 2024
ACS Appl Bio Mater - Level BClinical TrialPubMed
Comparison of the therapeutic effects of mesenchymal stem cells derived from human dental pulp (DP), adipose tissue (AD), placental amniotic membrane (PM), and umbilical cord (UC) on postmenopausal osteoporosis.
Clinical Trial on Immune Modulation, published in Front Pharmacol (2024) — summary generated from the PubMed abstract.
- 2024
Front Pharmacol - Level DLaboratory StudyEurope PMC
Human placental mesenchymal stromal cells are ciliated and their ciliation is compromised in preeclampsia
Laboratory Study on Systemic / IV, published in BMC Med (2022) — summary generated from the PubMed abstract.
- 2022
BMC Med20 citations - Level DAnimal StudyEurope PMC
Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis
Animal Study on Cardiovascular Disease, published in BMC Cardiovasc Disord (2022) — summary generated from the PubMed abstract.
- 2022
BMC Cardiovasc Disord29 citations - Level DAnimal StudyEurope PMC
Exosomes derived from human placental mesenchymal stem cells enhanced the recovery of spinal cord injury by activating endogenous neurogenesis
Animal Study on Spinal Cord Injury, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cell Res Ther76 citations - Level CProspective StudyEurope PMC
Human Placental Mesenchymal Stem/Stromal cells (pMSCs) inhibit agonist-induced platelet functions reducing atherosclerosis and thrombosis phenotypes
Prospective Study, published in J Cell Mol Med (2021) — summary generated from the PubMed abstract.
- 2021
J Cell Mol Med14 citations - Level DLaboratory StudyPubMed
Comparison of the Cytokine Profile in Mesenchymal Stem Cells from Human Adipose, Umbilical Cord, and Placental Tissues.
Laboratory Study on Face & Skin, published in Cell Reprogram (2021) — summary generated from the PubMed abstract.
- 2021
Cell Reprogram - Level BClinical TrialPubMed
Immunomodulatory properties of human placental mesenchymal stem/stromal cells.
Clinical Trial on Type 1 Diabetes, Neuroinflammation, Immune Modulation, published in Placenta (2017) — summary generated from the PubMed abstract.
- 2017
Placenta - Level DAnimal StudyEurope PMC
Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury
Animal Study on Face & Skin, published in Stem Cells Transl Med (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Transl Med31 citations - Level DLaboratory StudyPubMed
Differentiation of adipocytes and osteocytes from human adipose and placental mesenchymal stem cells.
Laboratory Study on Immune Modulation, published in Iran J Basic Med Sci (2015) — summary generated from the PubMed abstract.
- 2015
Iran J Basic Med Sci24 citations - Level DLaboratory StudyPubMed
Multiplex analysis of cytokines, chemokines, growth factors, MMP-9 and TIMP-1 produced by human bone marrow, adipose tissue, and placental mesenchymal stromal cells.
Laboratory Study on Chronic Inflammation, Immune Modulation, published in Bull Exp Biol Med (2011) — summary generated from the PubMed abstract.
- 2011
Bull Exp Biol Med - Level DNarrative ReviewPubMed
Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation.
Narrative Review, published in Stem Cell Rev Rep (2009) — summary generated from the PubMed abstract.
- 2009
Stem Cell Rev Rep
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406